Literature DB >> 21440094

Nanoscale hydroxyapatite particles for bone tissue engineering.

Hongjian Zhou1, Jaebeom Lee.   

Abstract

Hydroxyapatite (HAp) exhibits excellent biocompatibility with soft tissues such as skin, muscle and gums, making it an ideal candidate for orthopedic and dental implants or components of implants. Synthetic HAp has been widely used in repair of hard tissues, and common uses include bone repair, bone augmentation, as well as coating of implants or acting as fillers in bone or teeth. However, the low mechanical strength of normal HAp ceramics generally restricts its use to low load-bearing applications. Recent advancements in nanoscience and nanotechnology have reignited investigation of nanoscale HAp formation in order to clearly define the small-scale properties of HAp. It has been suggested that nano-HAp may be an ideal biomaterial due to its good biocompatibility and bone integration ability. HAp biomedical material development has benefited significantly from advancements in nanotechnology. This feature article looks afresh at nano-HAp particles, highlighting the importance of size, crystal morphology control, and composites with other inorganic particles for biomedical material development.
Copyright © 2011 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21440094     DOI: 10.1016/j.actbio.2011.03.019

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  148 in total

1.  Substituted hydroxyapatites for bone repair.

Authors:  Jennifer H Shepherd; David V Shepherd; Serena M Best
Journal:  J Mater Sci Mater Med       Date:  2012-03-03       Impact factor: 3.896

Review 2.  Leveraging "raw materials" as building blocks and bioactive signals in regenerative medicine.

Authors:  Amanda N Renth; Michael S Detamore
Journal:  Tissue Eng Part B Rev       Date:  2012-05-21       Impact factor: 6.389

3.  Human amniotic membrane for guided bone regeneration of calvarial defects in mice.

Authors:  Mathilde Fénelon; Olivier Chassande; Jérome Kalisky; Florelle Gindraux; Stéphanie Brun; Reine Bareille; Zoran Ivanovic; Jean-Christophe Fricain; Claudine Boiziau
Journal:  J Mater Sci Mater Med       Date:  2018-06-01       Impact factor: 3.896

4.  Development of Modular, Dual-Perfused Osteochondral Constructs for Cartilage Repair.

Authors:  Ethan L H Daley; Jochen Kuttig; Jan P Stegemann
Journal:  Tissue Eng Part C Methods       Date:  2019-03       Impact factor: 3.056

5.  Magnetic resonance functional nano-hydroxyapatite incorporated poly(caprolactone) composite scaffolds for in situ monitoring of bone tissue regeneration by MRI.

Authors:  Nitya Ganesh; Anusha Ashokan; Ramiah Rajeshkannan; Krishnaprasad Chennazhi; Manzoor Koyakutty; Shantikumar V Nair
Journal:  Tissue Eng Part A       Date:  2014-08-20       Impact factor: 3.845

6.  Nonlinear effects of nanoparticles: biological variability from hormetic doses, small particle sizes, and dynamic adaptive interactions.

Authors:  Iris R Bell; John A Ives; Wayne B Jonas
Journal:  Dose Response       Date:  2013-11-07       Impact factor: 2.658

7.  Fabrication mechanism of nanostructured HA/TNTs biomedical coatings: an improvement in nanomechanical and in vitro biological responses.

Authors:  Shahab Ahmadi; Zohreh Riahi; Aylar Eslami; S K Sadrnezhaad
Journal:  J Mater Sci Mater Med       Date:  2016-08-31       Impact factor: 3.896

8.  Calcium orthophosphates (CaPO4): occurrence and properties.

Authors:  Sergey V Dorozhkin
Journal:  Prog Biomater       Date:  2015-11-19

9.  Protein adsorption on single-crystal hydroxyapatite particles with preferred orientation to a(b)- and c-axes.

Authors:  Zhi Zhuang; Mamoru Aizawa
Journal:  J Mater Sci Mater Med       Date:  2013-02-06       Impact factor: 3.896

10.  High-scale yield of nano hydroxyapatite through combination of mechanical activation and chemical dispersion.

Authors:  Xueling Gao; Chunchu Dai; Weiwei Liu; Yumei Liu; Ru Shen; Xiaotong Zheng; Ke Duan; Jie Weng; Shuxin Qu
Journal:  J Mater Sci Mater Med       Date:  2017-04-21       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.